Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ====== Fourth ventricle tumor ====== {{ :pasted:20240903-113157.png?400}} {{rss>https://pubmed.ncbi.nlm.nih.gov/rss/search/16koWIt7v5kDs6oXmnYldTmPjZXLl2xICfjvl4q8BHqhkRvopB/?limit=15&utm_campaign=pubmed-2&fc=20240903033854}} ---- [[Fourth ventricle tumor]]s are rare, and surgical series are typically small, comprising a single pathology, or focused exclusively on pediatric populations. ((Ferguson SD, Levine NB, Suki D, Tsung AJ, Lang FF, Sawaya R, Weinberg JS, McCutcheon IE. The surgical treatment of tumors of the fourth ventricle: a single-institution experience. J Neurosurg. 2017 Apr 14:1-13. doi: 10.3171/2016.11.JNS161167. [Epub ahead of print] PubMed PMID: 28409732. )). Primary fourth ventricular tumors are common in children but rare in adults. In addition, the disease categories encountered differ according to the patient’s age; in adults, the most common fourth ventricular neoplasm is metastasis ((Osborn AG. Brain tumors and tumorlike masses: classification and diffrential diagnosis. In Patterson AS, ed. Diagnostic neuroradiology. 1st ed. St. Louis: Mosby-Year Book, 1994:401-528)) ===== Classification ===== see [[Fourth ventricle tumor differential diagnosis]]. ===== Differential diagnosis ===== [[Fourth ventricle tumor differential diagnosis]]. ===== Treatment ===== ---- As part of a pilot clinical trial to treat recurrent malignant brain tumors in children, seven patients underwent posterior fossa craniotomy and placement of a ventricular catheter under direct vision into the fourth ventricle. The catheter was placed without passing through any brain parenchyma. It was then connected to a VAD placed subcutaneously at the inferior aspect of the incision. Three of the seven patients underwent simultaneous subtotal resection of recurrent tumor located in the fourth ventricle or cerebellum, and one patient underwent simultaneous tumor biopsy. The VAD was used to administer chemotherapy (methotrexate) in five of the seven patients. Six patients had no new neurological deficits after surgery, and one patient had partial left-sided facial weakness that was attributed to resection of tumor close to the floor of the fourth ventricle. No new neurological deficits were caused by VAD placement or by methotrexate infusions into the fourth ventricle. A VAD for chemotherapy infusion can be placed safely into the fourth ventricle without damaging the brainstem or cerebellum. Attention to anatomical details specific to the fourth ventricle are important when placing a fourth ventricle VAD and when using it to administer chemotherapy ((Sandberg DI, Kerr ML. Ventricular access device placement in the fourth ventricle to treat malignant fourth ventricle brain tumors: technical note. Childs Nerv Syst. 2015 Nov 23. [Epub ahead of print] PubMed PMID: 26597683.)). ===== Fourth ventricle tumor surgery ===== see [[Fourth ventricle tumor surgery]]. ===== Case report from the HGUA ===== ==== Q12174 ==== A 4-year-old male with gait instability, fever, and vomiting was diagnosed with an infratentorial mass in the fourth ventricle. The lesion causes tetraventricular hydrocephalus and transependymal edema. The differential diagnosis includes posterior fossa ependymoma and medulloblastoma. {{:pasted:20240903-113157.png?300}} fourth_ventricle_tumor.txt Last modified: 2025/04/03 20:16by 127.0.0.1